Related Experiment Videos

[Change in argatroban concentration within the vessel wall after local administration using hydrogel-coated balloon

T Imanishi1, M Arita, K Shiizaki

  • 1Department of Cardiology, Wakayama Medical College, Japan.

Insights

This study shows hydrogel-coated balloons effectively deliver argatroban to the arterial wall during angioplasty. This method ensures localized drug delivery, potentially reducing complications like acute coronary occlusion.

Area of Science:

  • Cardiovascular Medicine
  • Biomaterials Science
  • Interventional Cardiology

Background:

  • Acute coronary occlusion is a significant risk following percutaneous transluminal coronary angioplasty.
  • Effective local drug delivery to the arterial wall remains a challenge in coronary interventions.

Purpose of the Study:

  • To evaluate the efficacy of a hydrogel-coated balloon for delivering argatroban to the arterial wall.
  • To assess the persistence of argatroban in the arterial wall after angioplasty.

Main Methods:

  • A hydrogel-coated balloon catheter was used to deliver argatroban to the common carotid artery in 17 rabbits.
  • The balloon was immersed in an argatroban/saline solution and inflated within the artery.
  • Argatroban concentrations in the arterial wall were measured using high-performance liquid chromatography at various time points post-inflation.

Main Results:

  • The hydrogel-coated balloon successfully transferred argatroban to the vascular wall.
  • Argatroban concentrations in the arterial wall were measured at 14.8 nmole/g.wet weight immediately after deflation, decreasing to 4.2 nmole/g.wet weight at 5 minutes and 3.9 nmole/g.wet weight at 15 minutes.

Conclusions:

  • Hydrogel-coated balloon technology enables localized delivery of argatroban to the arterial wall during angioplasty.
  • This approach holds promise for mitigating acute coronary occlusion and improving outcomes in coronary interventions.

Related Concept Videos